| Aug 27 2025 |
This Week in 340B: August 19 – 25, 2025 |
McDermott Will & Schulte LLP |
| Aug 27 2025 |
Food and Chemicals Unpacked: EPR You Keeping Up? [Podcast] |
Keller and Heckman LLP |
| Aug 27 2025 |
The Not So Dormant Commerce Clause |
Bradley Arant Boult Cummings LLP |
| Aug 27 2025 |
Japan’s AMED Offers ‘Double Match Up’ Grants for Pharma Startups: Considerations for Investors and Companies |
Greenberg Traurig, LLP |
| Aug 27 2025 |
APHIS Withdraws Notices of Intent to Prepare EISs for Two Petitions Seeking Determinations of Nonregulated Status for Organisms Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
| Aug 27 2025 |
SB 951 and HB 3410: A Road Map for Medical Professionals in Oregon |
Epstein Becker & Green, P.C. |
| Aug 26 2025 |
July 2025 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Aug 25 2025 |
So You Want to Start a Concierge Medicine Practice? Here are Five Key Legal Considerations |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 25 2025 |
Court Denies Beverage Company’s Preliminary Injunction in Trade Secrets Case, Citing Conflicting Evidence |
ArentFox Schiff LLP |
| Aug 25 2025 |
Federal Request for Information on State Regulation and Interstate Commerce |
Keller and Heckman LLP |
| Aug 25 2025 |
Crank the Party Up: Is the DEA About to Get It On with Psilocybin? |
Bradley Arant Boult Cummings LLP |
| Aug 25 2025 |
Kessler Citizen Petition Addresses Refined Carbohydrates |
Keller and Heckman LLP |
| Aug 25 2025 |
FDA to Discuss Allergen Thresholds in Three-Day Public Meeting |
Keller and Heckman LLP |
| Aug 25 2025 |
FDA Updates Post-Market Assessment List |
Keller and Heckman LLP |
| Aug 25 2025 |
Leaked MAHA Report Proposes Overhaul of Children’s Health Policy |
Keller and Heckman LLP |
| Aug 24 2025 |
Claiming A Range, Watch Out For The Presumption Of Obviousness |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 22 2025 |
McDermott+ Check-Up – August 22, 2025 |
McDermott Will & Schulte LLP |
| Aug 21 2025 |
Illinois Law Subjects Out-Of-State Companies to General Personal Jurisdiction |
K&L Gates LLP |
| Aug 21 2025 |
Trade Policy Update: 407 New Products Added to Steel and Aluminum Tariff List |
Barnes & Thornburg LLP |
| Aug 21 2025 |
This Week in 340B: August 12 – 18, 2025 |
McDermott Will & Schulte LLP |
| Aug 21 2025 |
Identical or Not? Jury Can’t Decide Issues of Claim Construction |
McDermott Will & Schulte LLP |
| Aug 19 2025 |
What You Need to Know: Texas Substantially Expands Medical Cannabis Program |
Bradley Arant Boult Cummings LLP |
| Aug 19 2025 |
Bipartisan Bill Would Strengthen American Biomanufacturing |
Bergeson & Campbell, P.C. |
| Aug 18 2025 |
MN Rewrote the MinnesotaCare Tax Rules — But Tax Committees Never Saw It Coming |
Jones Walker LLP |
| Aug 18 2025 |
The FTC Goes All In on Head-To-Head Competition for Pipeline Medical Devices Merger Challenge |
Katten |
| Aug 16 2025 |
Life Sciences Industry Basics |
Financial Poise |
| Aug 16 2025 |
Recent Federal Developments for August 2025 |
Bergeson & Campbell, P.C. |
| Aug 15 2025 |
Telehealth and “In-Person Visits”: Tracking Federal and State Updates to Pandemic Era Telehealth Exceptions |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 14 2025 |
S1 E6: Dr. Connie Lehman on AI and the Future of Breast Cancer Prevention [Podcast] |
Polsinelli PC |
| Aug 14 2025 |
Proposed TRUTH in Labeling Act Would Mandate FOP Labeling |
Keller and Heckman LLP |
| Aug 14 2025 |
Judge Upholds New York City Kava Ban |
Keller and Heckman LLP |
| Aug 14 2025 |
FDA in Flux — August 2025 Newsletter |
Mintz |
| Aug 13 2025 |
HRSA Issues 340B Rebate Model Pilot Program Guidance, Requests Comments |
McDermott Will & Schulte LLP |
| Aug 13 2025 |
This Week in 340B: August 5 – 11, 2025 |
McDermott Will & Schulte LLP |
| Aug 13 2025 |
Three Key Reasons Why Securities Class Actions Are Failing on Material Misrepresentation Grounds in the District of Massachusetts |
Pierce Atwood LLP |
